Journal rankings · indicator year 2013
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2013
Immunology journal rankings 2013
86 ranked journals · Subfield in Immunology and Microbiology
Immunology has 86 ranked journals in 2013. The median OJR fell 0.05 on 2012 to 1.04, above the world average of 1.00; Q1 starts at OJR 1.61. The top three are Nature Immunology, Immunity, and The Journal of Experimental Medicine.
Ranks and citation indicators: 2013. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2010–2012, the window the 2013 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Immunology and Microbiology (5)
86 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2012. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2010–2012, the window the 2013 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2010–2012 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2004 to 2013. | Compare |
|---|---|---|---|---|---|---|---|
1Nature ImmunologyNature Portfolio · United States | 6.15Q1 | 15.53 3.36 down from 2012 | 689 | 46% | $12,690 | ||
2ImmunityCell Press · United States | 5.96Q1 | 17.65 0.31 up from 2012 | 656 | 100% | $10,400 | ||
3The Journal of Experimental MedicineRockefeller University Press · United States | 4.93Q1 | 14.72 1.16 up from 2012 | 780 | 93% | — | ||
4Annual Review of ImmunologyAnnual Reviews · United States | 3.51Q1 | 49.04 0.91 up from 2012 | 72 | 67% | — | ||
5Seminars in ImmunopathologySpringer Science+Business Media · Germany | 3.26Q1 | 8.41 0.51 up from 2012 | 165 | 65% | $3,790 | ||
6Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 3.13Q1 | 7.94 0.71 down from 2012 | 1,649 | 52% | $4,900 | ||
7Mucosal ImmunologyOAElsevier BV · United States | 2.63Q1 | 6.98 0.10 up from 2012 | 269 | 100% | $4,370 | ||
8Seminars in ImmunologyElsevier BV · United States | 2.43Q1 | 8.03 1.81 up from 2012 | 152 | 42% | $4,370 | ||
9Journal of AutoimmunityElsevier BV · United Kingdom | 2.33Q1 | 7.57 0.19 up from 2012 | 254 | 40% | $5,420 | ||
10Nature reviews. ImmunologyNature Portfolio · United Kingdom | 2.22Q1 | 13.34 1.38 down from 2012 | 632 | 19% | — | ||
11The AAPS JournalSpringer Science+Business Media · United States | 2.18Q1 | 4.49 0.07 down from 2012 | 280 | 96% | $5,090 | ||
12The Journal of ImmunologyAmerican Association of Immunologists · United States | 2.16Q1 | 6.22 0.26 down from 2012 | 4,465 | 23% | $3,500 | ||
13Journal of Innate ImmunityOAKarger Publishers · Switzerland | 2.03Q1 | 4.81 0.05 down from 2012 | 193 | 92% | $3,590 | ||
14Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 1.97Q1 | 4.97 0.28 up from 2012 | 144 | 14% | $5,490 | ||
15International Reviews of ImmunologyTaylor & Francis · United States | 1.86Q1 | 6.58 0.12 down from 2012 | 82 | 27% | — | ||
16Journal of Leukocyte BiologyOxford University Press · United States | 1.82Q1 | 4.88 0.19 down from 2012 | 643 | 42% | $3,800 | ||
17International Journal of InflammationOAHindawi Publishing Corporation · United Kingdom | 1.74Q1 | 4.06 0.08 up from 2012 | 99 | 100% | $1,000 | ||
18Frontiers in ImmunologyOAFrontiers Media · Switzerland | 1.68Q1 | 4.52 3.13 up from 2012 | 522 | 100% | $3,801 | ||
19Clinical and Developmental ImmunologyOAHindawi Publishing Corporation · United Kingdom | 1.68Q1 | 4.13 0.46 up from 2012 | 438 | 100% | $2,100 | ||
20Genes and ImmunitySpringer Nature · United States | 1.67Q1 | 4.49 0.54 up from 2012 | 226 | 51% | $3,190 | ||
21Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.62Q1 | 4.12 0.46 down from 2012 | 477 | 24% | — | ||
22Critical Reviews in ImmunologyBegell House · United States | 1.61Q1 | 5.33 0.92 up from 2012 | 81 | 45% | — | ||
23European Journal of ImmunologyWiley · Germany | 1.53Q2 | 4.42 0.50 down from 2012 | 1,191 | 73% | $4,550 | ||
24Immunologic ResearchSpringer Science+Business Media · United States | 1.53Q2 | 4.18 0.23 up from 2012 | 237 | 34% | $2,890 | ||
25Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.45Q2 | 3.70 0.22 down from 2012 | 638 | 92% | $3,816 | ||
26Journal of Interferon & Cytokine ResearchMary Ann Liebert, Inc. · United States | 1.39Q2 | 3.49 0.40 down from 2012 | 273 | 50% | — | ||
27Clinical ImmunologyElsevier BV · Netherlands | 1.39Q2 | 4.16 0.28 up from 2012 | 488 | 20% | $4,400 | ||
28International ImmunologyOxford University Press · United Kingdom | 1.33Q2 | 2.86 0.41 down from 2012 | 317 | 52% | $3,530 | ||
29Immunity & AgeingOABioMed Central · United Kingdom | 1.31Q2 | 4.15 1.21 up from 2012 | 63 | 100% | $3,190 | ||
30Immunology and Cell BiologyWiley · Australia | 1.31Q2 | 4.63 0.96 up from 2012 | 370 | 45% | $3,750 | ||
31Inflammation & Allergy - Drug TargetsBentham Science Publishers · Netherlands | 1.29Q2 | 2.97 0.13 down from 2012 | 146 | 9% | — | ||
32BMC ImmunologyOABioMed Central · United Kingdom | 1.29Q2 | 2.94 0.49 down from 2012 | 209 | 100% | $3,090 | ||
33American Journal of Reproductive ImmunologyWiley · United Kingdom | 1.29Q2 | 2.93 0.78 down from 2012 | 428 | 33% | $4,460 | ||
34BioDrugsAdis, Springer Healthcare · Switzerland | 1.24Q2 | 2.26 1.50 down from 2012 | 162 | 27% | $5,190 | ||
35Cellular and Molecular ImmunologySpringer Nature · China | 1.23Q2 | 3.81 0.02 down from 2012 | 219 | 100% | $5,190 | ||
36Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.23Q2 | 2.84 1.00 down from 2012 | 488 | 36% | $4,990 | ||
37ImmunologyWiley · United Kingdom | 1.19Q2 | 3.29 0.28 down from 2012 | 561 | 78% | $5,330 | ||
38ImmunobiologyOAElsevier BV · Germany | 1.19Q2 | 3.04 0.06 down from 2012 | 478 | 20% | $2,840 | ||
39Innate ImmunityOASAGE Publishing · United Kingdom | 1.16Q2 | 3.08 0.68 up from 2012 | 181 | 42% | $2,650 | ||
40Developmental & Comparative ImmunologyElsevier BV · United Kingdom | 1.16Q2 | 4.01 0.63 up from 2012 | 489 | 16% | $3,340 | ||
41CytokineElsevier BV · United Kingdom | 1.13Q2 | 2.99 0.15 up from 2012 | 889 | 13% | $3,220 | ||
42Molecular ImmunologyElsevier BV · Netherlands | 1.07Q2 | 2.95 0.26 down from 2012 | 721 | 14% | $3,340 | ||
43Toxicologic PathologySAGE Publishing · United States | 1.07Q2 | 2.40 0.11 down from 2012 | 393 | 41% | $4,150 | ||
44Immunological ReviewsWiley · United States | 1.01Q3 | 14.70 0.31 down from 2012 | 324 | 65% | $5,000 | ||
45Immunology LettersElsevier BV · Netherlands | 0.99Q3 | 2.96 0.33 up from 2012 | 394 | 17% | $3,290 | ||
46Trends in ImmunologyElsevier BV · United Kingdom | 0.95Q3 | 14.42 3.08 up from 2012 | 241 | 56% | $7,030 | ||
| 0.94Q3 | 2.00no 2012 value | 55 | 95% | — | — | ||
48ImmunogeneticsSpringer Science+Business Media · Germany | 0.91Q3 | 2.94 0.32 down from 2012 | 247 | 45% | $2,890 | ||
49Journal of Immunological MethodsElsevier BV · Netherlands | 0.91Q3 | 2.23 0.37 down from 2012 | 573 | 34% | $2,970 | ||
50Journal of ImmunotoxicologyOAInforma · United States | 0.91Q3 | 2.12 0.12 up from 2012 | 152 | 98% | $2,306 |
Subfields of Immunology and Microbiology, with Immunology highlighted.
Journals
Citations made in 2013. Corpus-wide, 76.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
23 additional Immunology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2010–2012, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2013. Publication window: 2010–2012. How these summaries are calculated
- Ranked journals
- 86
- Window papers (baseline)
- 67,579 +7.1% from indicator year 2010
- Median OJR
- 1.04 -5.3% from indicator year 2010
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2010–2012 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 56 | 59 | 63 | 65 | 62 | 64 | 68 | 72 | 71 | 74 | 76 | 79 | 81 | 86 | 83 | 88 | 90 | 96 | 94 | 90 | 92 | 87 | 88 | 88 | 88 | 86 | |
| Window papers (baseline) | 33,673 | 35,811 | 37,963 | 40,362 | 42,065 | 44,849 | 47,600 | 50,960 | 53,923 | 57,726 | 63,072 | 65,596 | 67,601 | 67,579 | 70,684 | 72,624 | 73,354 | 72,790 | 72,098 | 72,447 | 74,045 | 77,362 | 81,615 | 83,779 | 84,353 | 84,391 | |
| Median OJR | 0.72 | 0.78 | 0.834 | 0.82 | 0.830 | 0.88 | 0.89 | 0.959 | 1.002 | 1.15 | 1.100 | 1.09 | 1.096 | 1.04 | 1.08 | 1.06 | 1.05 | 0.95 | 0.921 | 0.970 | 0.931 | 0.932 | 0.967 | 0.956 | 0.922 | 0.87 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.